About Talus Bio
Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
AI & Machine Learning
Funding Stage
Seed
Global Headquarters
Seattle, United States
Team Size
16 employees
Tracked Since
Sep 28, 2026
Web & Domain Identity
Official Website
talus.bio
Domain Registered Date
Undisclosed
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
- Capital Raise
Seed announced
fundraisingfox.com
- Milestone
X account created (@talusbio)
674 followers
Investors & Backers
BoxOne Ventures
Farvatn Venture
FundersClub
NCATS
NFX
Plug and Play
Rolling Bay Ventures
Two Bear Capital
WRF Capital
Y Combinator
YC Continuity
Funding History
Seed
· Sep 21, 2026
Undisclosed
Seed
· Jun 7, 2022
Undisclosed fundraisingfox.com
Venture Round
· Undisclosed
Undisclosed Source
Founders & Leadership
Press Coverage & Sources
Recently Funded AI & Machine Learning Startups
View allPathos
pathos.com
Series-B+ New York, United States · Oct 2026
Guoke Brain-Computer Intelligence Technology
gkxn.com.cn
Seed Beijing, China · Oct 2026
Knowledge Work
knowledgework.com
Series-B+ Minato, Japan · Oct 2026
Satia
satia.so
Pre-Seed Oct 2026
karta
getkarta.ai
Seed Bangalore, India · Oct 2026
Reduck
reduck.ai
Pre-Seed Oct 2026